IDEXX Labs (IDXX) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $671.64 +21.85%
Financial Fact:
Total cost of revenue: 201.58M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Total cost of revenue: 201.58M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $1.56, $0.09 worse than the analyst estimate of $1.65. Revenue for the quarter came in at $861 million versus the consensus estimate of $864.61 million.
GUIDANCE:
IDEXX Labs sees FY2022 EPS of $7.77-$8.05, versus the consensus of $8.27. IDEXX Labs sees FY2022 revenue of $3.3-3.38 billion, versus the consensus of $3.42 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDEXX Labs (IDXX) Tops Q3 EPS by 24c ; Offers Guidance
- Sinda Ltd. (SIND) Reports Q3 Loss of $0.10
- Hinge Health, Inc. (HNGE) Tops Q3 EPS by 6c, raises Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
